Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses (Details) - Schedule of accrued expenses

v3.22.1
Accrued Expenses (Details) - Schedule of accrued expenses - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Schedule of accrued expenses [Abstract]    
Clinical research organization services and expenses $ 995,088 $ 1,826,479
Employee compensation 357,535 520,795
Preclinical and manufacturing expenses 293,150
Legal and consulting services 39,058 29,656
Minimum license royalties 10,000
Total accrued expenses $ 1,694,831 $ 2,376,930